News archive

Using human lung and liver cells, Chinese researchers have observed that nano plastics of 80 nm in size have a disturbing effect on energy and cellular metabolism.

In cell culture, researchers from Philadelphia have discovered a new mechanism that could inhibit the deposition of the feared alpha-synuclein.

The Berlin State Animal Welfare Officer promotes the development and application of animal-free methods in basic and applied research.

The PETA Science Consortium International (PISC) will help give an early career scientist the opportunity to learn about the latest developments in genetic toxicology and get hands-on experience with some of these new methods.

European animal protection organizations have collected 1.4 million online signatures for the European Citizens' Initiative to phase out animal experiments. Member of the German Parliament, Luiza Licina Bode, the animal welfare representative of the Social Democrats' parliamentary group in the Parliament as well as of the Parliament's Committee on Food and Agriculture, calls for a long-term commitment beyond the agreement in the coalition treaty.

A group of international companies developing human-on-a-chip technologies has reached out to key members of the U.S. Congress, urging them to support the so-called FDA Modernization Act as part of a legislative package.

Two research teams from Freiburg will receive funding of a total of 200,000 euros this year for their research into methods that do not involve animal experiments. Their planned models are suitable for at least reducing animal experiments in certain areas.

Heart disease can be caused by mutations

Monday, 22 August 2022 18:59

Scientists at Boston Children's Hospital have developed a new approach to understanding heart diseases. They examined heart muscle cells from patients of all ages and found that mutations accumulate in the cells over time with a loss of ability to eliminate them over a lifetime.

Congenital heart research in vitro

Tuesday, 16 August 2022 14:29

A team of researchers from Michigan State University (MSU) has presented a human pluripotent stem cell-based method for producing developmentally relevant human heart organoids that can be used for gestational diabetes research.

The European Food and Safety Authority (EFSA) has launched a call for tender to develop an action plan for the application of omics and bioinformatics approaches.